Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in glenmark

Glenmark's consolidated revenue grew by 0.94 per cent at Rs 23,447.87 million for Q1 FY 2020-21

Glenmark's consolidated revenue grew by 0.94 per cent at Rs 23,447.87 million for Q1 FY 2020-21

Read More

Glenmark introduces higher strength (400 mg) of FabiFlu® to reduce the pill burden of COVID-19 treatment

Glenmark introduces higher strength (400 mg) of FabiFlu® to reduce the pill burden of COVID-19 treatment

Read More

Glenmark announces top-line results from phase 3 clinical trial of Favipiravir in patients with mild to moderate COVID-19

Glenmark announces top-line results from phase 3 clinical trial of Favipiravir in patients with mild to moderate COVID-19

Read More

COVID-19: Glenmark's Favipiravir drug shows encouraging results in Phase 3 clinical trial

COVID-19: Glenmark's Favipiravir drug shows encouraging results in Phase 3 clinical trial

Read More

Glenmark responds to DCGI letter seeking clarification on Fabiflu

Glenmark responds to DCGI letter seeking clarification on Fabiflu

Read More

Glenmark Cuts Price Of COVID-19 Drug Favipiravir Version To $1 Per Tablet

A treatment course with FabiFlu would require a patient to take 122 tablets over 14 days, and will now cost 8,475 rupees ($112.80) per patient at the new price.

Read More

HUL Completes Acquisition Of Female Hygiene Brand Vwash From Glenmark

The shares of HUL were trading at Rs 2,149 apiece on BSE, down 1.15 per cent from their previous close.

Read More

Anti-viral Drug Favipiravir Shows Clinical Improvement In Mild, Moderate COVID-19 Cases: Glenmark

However, it said that pregnant and lactating mothers were not included in the clinical trial.

Read More

Anti-viral drug favipiravir gets DGCI nod for 'restricted emergency use' in mild to moderate COVID-19 cases

Anti-viral drug favipiravir gets DGCI nod for 'restricted emergency use' in mild to moderate COVID-19 cases

Read More

Glenmark To Conduct Trials In India For Potential COVID-19 Drug

Glenmark will initially enroll 150 patients with mild-to-moderate COVID-19 in a randomized trial that will compare favipiravir with standard supportive care.

Read More

HUL Share Price Jumps 8 Pc After Acquiring Vwash Brand From Glenmark

HUL is India's largest fast-moving consumer goods (FMCG) company with its products touching the lives of nine out of ten households in the country.

Read More

Dr Reddy’s, Sun Pharma, Glenmark Face US price Fixing Charge

The states are seeking to expand the complaint to include Actavis Holdco US, Actavis Pharma, Ascend Laboratories, Apotex Corp, Dr Reddy’s Laboratories (DRL), Emcure Pharmaceuticals, Glenmark Pharmaceuticals, Lannett Company, etc.

Read More

Glenmark Pharma: A Healthy Dose Of Growth

Glenmark, which has graduated to a global organisation in a very short span with its expanded manufacturing footprint, international operations and global employee base, reported a 276.08 per cent rise in revenue since 2012

Read More

Glenmark Stock Up After US Approval To Its Savella Generic

Shares of drug maker Glenmark Pharmaceuticals rose 0.52 per cent to Rs 868. 45 a unit on BSE on Friday, a day that saw the benchmark Sensex down by at least 50 points

Read More

Glenmark, Evestra To Jointly Develop And Sell NuvaRing Copy In US

Drug maker Glenmark and Evestra Inc, a San Antonio-based biopharmaceutical research and development company with focus in women’s healthcare, have signed a licensing and commercialization agreement for development and marketing of a generic version of Merck & Co.’s NuvaRing, for the US market

Read More